skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Please comment on the earnings for the two that have reported and whether they are a buy, sell or hold. SRAD at $27 seems like a good deal with what they reported. Investors seem to disagree this morning. Would appreciate your thoughts on that and the market reaction to GENI as well. I know you always look for a change in fundamentals to guide your advice so I am curious if the thesis is improved or reduced.

Please answer this one after GENI has reported if possible.
Read Answer Asked by Tim on August 06, 2025
Q: Thoughts on GAMB after earnings? Can you comment on why earnings seemed good but it dropped? The Donville group seem to love it and they are right almost as often as you guys so I'd love to have your take on whether you would buy at these levels and what you might see as it's 3 year return? Is there overlap with GENI or SRAD and is it a takeover candidate?

Thanks
Read Answer Asked by Tim on May 21, 2025
Q: Hi 5i Team,

Out of this basket of US small caps would you be able to rank these from best to worst for an investment? No need to provide details about what each company does but purely a ranking and whether there are any that you would stay away from.

Thanks as always,
Jon
Read Answer Asked by Jonathan on February 06, 2025
Q: Hi 5i Team - I have sold my shares in Score but am interested in investing in a company in the same space. Am considering buying Penn and am just wondering if this would be a good strategy. Also are there any companies similar to Score that you would recommend - Canadian or U.S, any size of market cap but small and mid cap are preferred. Thanks.
Read Answer Asked by Rob on October 12, 2021